Therapeutic Significance of NLRP3 Inflammasome in Cancer: Friend or Foe?

Aliea M Jalali1, Kenyon J Mitchell1, Christian Pompoco1

  • 1Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT 84606, USA.

Insights

The NLRP3 inflammasome plays a dual role in cancer, potentially aiding or hindering tumor progression and therapy. Understanding its complex inflammatory response is key to developing new cancer treatments.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Recent research highlights the NLRP3 inflammasome's involvement in cancer development and treatment.
  • The NLRP3 inflammasome's impact on cancer is context-dependent, influenced by the tumor microenvironment.

Purpose of the Study:

  • To review the multifaceted role of NLRP3 inflammasome-mediated inflammation in various cancer types.
  • To elucidate how understanding NLRP3 inflammasome activity can inform novel cancer therapeutic strategies.

Main Methods:

  • Literature review of studies investigating NLRP3 inflammasome in cancer pathophysiology.
  • Analysis of the dual effects of NLRP3 activation on anti-tumor immunity and pro-tumor inflammation.

Main Results:

  • NLRP3 activation can enhance anti-tumor immunity by recruiting immune cells and improving immunotherapy efficacy.
  • Conversely, chronic NLRP3-driven inflammation can promote tumor growth, invasion, and metastasis via cytokines like IL-1β and IL-18.
  • Sustained inflammation may lead to immune suppression, compromising anti-cancer responses.

Conclusions:

  • The NLRP3 inflammasome presents a complex target in cancer therapy, with both beneficial and detrimental roles.
  • Targeting NLRP3 inflammasome pathways requires careful consideration of the tumor microenvironment for effective cancer treatment development.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K